Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
The Motley Fool
OCTOBER 9, 2024
Thanks largely to news of a crucial legal settlement, GSK (NYSE: GSK) was one of the better-performing big pharma stocks on Wednesday. GSK announced Wednesday that it has agreed to a settlement with 10 plaintiffs' law firms representing around 80,000 Zantac cases -- 93% of the total number. billion to resolve all of those cases.
Let's personalize your content